| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 76,275 | 57,809 | 51,095 | | Cost of Revenue | 50,966 | 35,880 | 31,736 | | | Gross Profit | 25,309 | 21,929 | 19,359 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 18,266 | 15,716 | 12,461 | | Non Recurring |
-
|
-
|
-
| | Others | 2,948 | 2,785 | 2,354 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 4,095 | 3,428 | 4,544 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 4,095 | 3,428 | 4,544 | | Interest Expense | 479 | 637 | 372 | | Income Before Tax | 3,616 | 2,791 | 4,172 | | Income Tax Expense | 1,135 | 736 | 1,641 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,481 | 2,055 | 2,531 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,481 | 2,055 | 2,531 | | Preferred Stock And Other Adjustments |
-
|
-
| (4,655) | | | Net Income Applicable To Common Shares | $2,481 | $2,055 | ($2,124) |
|
1.23% Nasdaq 0.00%
Income Statement
